in

‎Jamjoom Pharma eyes 34.5% profit margin in 2025

‎Jamjoom Pharma eyes 34.5% profit margin in 2025

Tarek Youssef Hosny, CEO of Jamjoom Pharmaceuticals Factory Co. (Jamjoom Pharma)

Tarek Youssef Hosny, CEO of Jamjoom Pharmaceuticals Factory Co. (Jamjoom Pharma) expects the company to maintain its growth trajectory and long-term value creation.

“We are tracking well towards our revenue guidance of CAGR of 12–15% achieving a YTD growth of 13%…

Report

What do you think?

Newbie

Written by Mr Viral

Leave a Reply

Your email address will not be published. Required fields are marked *

GIPHY App Key not set. Please check settings

Edun presides over Afreximbank leadership transition in Cairo

Edun presides over Afreximbank leadership transition in Cairo

‎KDL Logistics issues prospectus for 20% Nomu IPO

‎KDL Logistics issues prospectus for 20% Nomu IPO